Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/88447
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | CCAAT/enhancer binding protein δ regulates glial proinflammatory gene expression |
Autor: | Valente, Tony; Straccia, Marco CSIC ORCID CVN; Gresa-Arribas, Nuria CSIC; Dentesano, Guido CSIC; Tusell, Josep Maria CSIC; Serratosa, Joan CSIC ORCID CVN; Mancera, Pilar CSIC; Solà, Carme CSIC ORCID; Saura, Josep CSIC ORCID | Palabras clave: | Transcription factors Neuroinflammation Amyotrophic lateral sclerosis Lipopolysaccharide Microglia |
Fecha de publicación: | 2013 | Editor: | Elsevier | Citación: | Neurobiology of Aging 34(9): 2110-2124 (2013) | Resumen: | The transcription factor CCAAT/enhancer binding protein δ (C/EBPδ) is expressed in activated astrocytes and microglia and can regulate the expression of potentially detrimental proinflammatory genes. The objective of this study was to determine the role of C/EBPδ in glial activation. To this end, glial activation was analyzed in primary glial cultures and in the central nervous system from wild type and C/EBPδ−/− mice. In vitro studies showed that the expression of proinflammatory genes nitric oxide (NO)synthase-2, cyclooxygenase-2, and interleukin (IL)-6 in glial cultures, and the neurotoxicity elicited by microglia in neuron–microglia cocultures, were decreased in the absence of C/EBPδ when cultures were treated with lipopolysaccharide (LPS) and interferon γ, but not with LPS alone. In C/EBPδ−/− mice, systemic LPS-induced brain expression of NO synthase-2, tumor necrosis factor-α, IL-1β, and IL-6 was attenuated. Finally, increased C/EBPδ nuclear expression was observed in microglial cells from amyotrophic lateral sclerosis patients and G93A-SOD1 mice spinal cord. These results demonstrate that C/EBPδ plays a key role in the regulation of proinflammatory gene expression in glial activation and suggest that C/EBPδ inhibition has potential for the treatment of neurodegenerative disorders, in particular, amyotrophic lateral sclerosis. | URI: | http://hdl.handle.net/10261/88447 | DOI: | 10.1016/j.neurobiolaging.2013.02.007 | Identificadores: | doi: 10.1016/j.neurobiolaging.2013.02.007 issn: 0197-4580 e-issn: 1558-1497 |
Aparece en las colecciones: | (IIBB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
27
checked on 24-mar-2024
WEB OF SCIENCETM
Citations
24
checked on 25-feb-2024
Page view(s)
379
checked on 28-mar-2024
Download(s)
113
checked on 28-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.